Funds vaccine to counter airborne exposure

31 Oct, 2014

The Pentagon provides a $9.5 million funding grant to the Profectus BioSciences to manufacture trivalent VesiculoVax™-vectored vaccine. Statement:

The lyophilized trivalent vaccine is being tested in both pre-exposure and post-exposure studies to confirm protection of non-human primates from aerosol exposure to Ebola and Marburg viruses.

Add your comments below...